Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Leflunomide
- OTHER: Pharmacological Study
Sponsor
City of Hope Medical Center
Collaborators